Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Science News / One in seven volunteers for Sputnik V report side effects
  • Science

    One in seven volunteers for Sputnik V report side effects

    Shubham Sharma
    Written by
    Shubham Sharma
    Twitter
    Last updated on Sep 18, 2020, 09:01 pm
    One in seven volunteers for Sputnik V report side effects
  • Sputnik V, the COVID-19 vaccine developed and approved by Russia, has shown side effects in some trial volunteers.

    The reactions, according to state-run news agency TASS, have been reported in about one in seven people who have been inoculated by the shot as part of a massive Phase-3 study.

    Here is all you need to know about it.

  • In this article
    14% subjects displayed reactions No serious effects seen so far Sputnik V involves a two-dose regimen Approval with pending trials, raised questions Still, Russia has been moving ahead with production, distribution Mass-vaccination drives likely to begin in October or November 100 million doses to be supplied to India
  • Study report

    14% subjects displayed reactions

  • In a recent conversation with TASS, Russian Health Minister Mikhail Murashko provided an update on the progress of the late-stage trial of Sputnik V.

    He said that the vaccine doses have been given to more than 300 of the planned 40,000 volunteers and about 14% of them have reported mild problems like weakness, muscle pain, and an increase in body temperature.

  • Serious effect

    No serious effects seen so far

    No serious effects seen so far
  • The minister emphasized that none of the volunteers have reported any serious side effects so far.

    Even for the 14% who witnessed the mild symptoms, the reactions last for 24 hours and level off by the next day.

    "The complications are described in the instructions (of the vaccine trial) and are predictable," he added while speaking to TASS.

  • Regimen

    Sputnik V involves a two-dose regimen

  • Notably, the Sputnik V vaccine is given in two doses at a gap of 21 days.

    Each dose uses a different adenovirus and the spike protein from the coronavirus to induce an antibody-based immune response against COVID-19.

    Last month, Russian President Vladimir Putin claimed that the shot forms a 'stable immunity,' and one of his daughters has already been inoculated.

  • Approval

    Approval with pending trials, raised questions

  • Even though the late-stage human trials of Sputnik V were not completed, Russia granted approval to the shot earlier last month, clearing it for public use.

    The move drew major flak from the scientific community, with many experts claiming that premature approval, and the lack of full safety and efficacy data, could put people at risk.

  • Distribution

    Still, Russia has been moving ahead with production, distribution

    Still, Russia has been moving ahead with production, distribution
  • Despite the alarms, Russia has been moving ahead with the production and distribution of the vaccine (for those at high-risk) while carrying out the late-stage trials at the same time.

    The country started mass-manufacturing last month and has already released the first batch of the shot in civil circulation, following necessary quality tests in the laboratories of Roszdravnadzor [Russia's medical device regulator].

  • Information

    Mass-vaccination drives likely to begin in October or November

  • Further, Russia is expected to begin mass-inoculation drives for Sputnik V in October or November, which is when the initial data from the Phase-3 trial is likely to be revealed.

  • Deal

    100 million doses to be supplied to India

    100 million doses to be supplied to India
  • The Russian Direct Investment Fund, the sovereign wealth fund that backed the Sputnik V project, has inked a deal with Hyderabad-based Dr. Reddy's Laboratories to conduct a clinical trial of the vaccine on the Indian population and supply 100 million doses.

    However, the progress of the trial and the supply of the doses would depend on approvals from India's Central Drugs Standard Control Organization.

  • Russia News
  • Vaccine
  • Vladimir Putin
  • Central Drugs Standard Control Organization
  • COVID-19
  •  
Latest News
  • NewsBytes Briefing: Investigation uncovers Facebook's pro ISIS move, and more
    NewsBytes Briefing: Investigation uncovers Facebook's pro ISIS move, and more
    Science
  • PUBG: New State announced for iOS, Android; Unavailable in India
    PUBG: New State announced for iOS, Android; Unavailable in India
    Science
  • Indian versions of 'Suits', 'House', 'Monk', 'SNL' are being planned
    Indian versions of 'Suits', 'House', 'Monk', 'SNL' are being planned
    Entertainment
  • Google integrates lightweight HTML5 games into Chrome browser on Android
    Google integrates lightweight HTML5 games into Chrome browser on Android
    Science
  • Sony announces next-generation PSVR headset for the PlayStation 5
    Sony announces next-generation PSVR headset for the PlayStation 5
    Science
Related Timelines
  • Severe side-effects after COVID-19 vaccine: What are your legal options?
    Severe side-effects after COVID-19 vaccine: What are your legal options?
    India
  • COVID-19 vaccine: India to produce 300 million Sputnik V doses
    COVID-19 vaccine: India to produce 300 million Sputnik V doses
    Science
  • India's neighbors train experts for clinical trials of COVID-19 vaccine
    India's neighbors train experts for clinical trials of COVID-19 vaccine
    India
  • US: FDA panel authorizes Pfizer-BioNTech's COVID-19 vaccine for emergency use
    US: FDA panel authorizes Pfizer-BioNTech's COVID-19 vaccine for emergency use
    World
Trending Topics
Samsung Facebook Amazon OnePlus Mobiles Android TV Smart TV Latest Gadget Launch MediaTek Dimensity 1000+ COVAXIN Latest Tech News Upcoming Mobile Phones
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love Science news?

Subscribe to stay updated.

Science Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Narendra Modi Facebook YouTube Hollywood News WhatsApp Bollywood News ISRO Rahul Gandhi Yoga
Honda Batman Football News BMW Vaccine Reliance Jio OPPO Amazon Food News, Healthy Recipes Royal Challengers Bangalore
Toyota Fashion Tips Farmers Protest Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics
Avengers Neha Kakkar Premier League Big Bang Theory
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021